FDA Approved: PLAQUENIL — Supplemental Application (Advanz Pharma (US) Corp.)

View source ↗

Summary

FDA approves a supplemental application for Plaquenil (hydroxychloroquine sulfate) submitted by Advanz Pharma (US) Corp.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Rheumatoid Arthritis
• Systemic Lupus Erythematosus

Drugs mentioned

• Plaquenil (hydroxychloroquine)

Snippet

SUPPL AP for PLAQUENIL (HYDROXYCHLOROQUINE SULFATE)